“中国数字疗法第一股”?脑动极光问题明显,时间是不安之源

深潜atom
18 Nov 2024

2020年,国家药品监督管理局审批通过了首款数字疗法产品,加速了该赛道的发展。在此后的2021年,疫情的推动、资本市场的支持以及政策和技术的进步共同作用下,数字疗法呈现井喷状态,甚至被称为数字疗法元年。伴随着疫情结束,医疗赛道重回平静,医疗大模型迅速崛起,数字疗法的市场声量在接下来几年竟然开始减缓。如今,这一趋势终于有望被反转。2024年8月22日,脑动极光在港交所披露聆讯后的招股书,即将成为“...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10